Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
However, researchers saw little difference across racial groups in HBV treatment initiation among those who were eligible.
Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.
Even without HBV immunoglobulin, no infants acquired hepatitis B from mothers with a high viral load.
The antiviral treatment is safe and effective for pediatric patients ages 12 and up.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
Treatment with Viread and Baraclude led to a decline in liver cancer in Europe but not in South Korea.
An analysis of two Gilead-sponsored studies suggests that black HIV-positive patients have a better chances of an undetectable viral load afte...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.